FDA pulls Darvon
Friday, November 19th, 2010
FDA pulls Darvon, generic Darvon (propoxyphene) and Darvocet from the market due to serious heart risks.
On November 19, 2010, Xanodyne Pharmaceuticals agreed to withdraw Darvon and Darvocet from the market in response to a request from the FDA. The FDA also requested that other drugmakers stop making and selling generic drugs containing propoxphene, the active ingredient in Darvon.
The recall is based on a recent study showing that Darvon may interfere with the electrical activity of the heart, causing irregular heart rhythms that can be fatal.
We are interested in the cases of people who have suffered from irregular heartbeats or heart rhythm abnormalities after taking Darvon, Darvocet or propoxphene. Please contact us immediately at 417.869.3737, 888.326.5475 or firstname.lastname@example.org.